): The University of Iowa Oncology Research Training Program is designed to support postdoctoral research training in a mentored environment for outstanding M.D.'s and Ph.D.'s who wish to become cancer researchers and acquire the knowledge and skills necessary to perform independent cancer research including basic laboratory and clinical research. The program is based on the expertise of 30 experienced faculty members who are members of the Cancer Center at the University of Iowa. General areas of expertise include 1) Cancer immunotherapy, 2) Cellular activation and tumor biomarkers, 3) Clinical oncology with an emphasis on urologic oncology and bone marrow transplantation, 4) Molecular mechanisms of metastasis, 5) Free radicals and cancer, and 6) Cancer epidemiology. The majority of candidates will have the M.D. degree, and have completed both their residency training and the clinically intensive portion of their subspecialty oncology training. A minority of trainees will have a Ph.D. and a stated commitment to pursuing a career in cancer research. During the period of support, at least 75 percent of participants' time will be devoted to cancer research training. The program will be based within The University of Iowa Cancer Center. The three-year curriculum will be divided into the initial year (core year) and two years dedicated directly to research training (research years). During the first six months of the core year, all trainees will participate in clinical research and basic research rotations to gain a familiarity with various aspects of state-of-the-art basic oncologic r e s earch. In addition, they will attend classes in cancer biology, epidemiology/biostatistics, informatics, and medical ethics. They will also begin an intensive period of cancer research training under the mentorship of an experienced cancer investigator. Mentored research will be continued during the research years. Progress of trainees will be monitored continuously by a personal mentoring committee and by the program advisory committee and Program Director. On completion of the program, it is expected that trainees will have a thorough understanding of the various aspects of cancer research, and be able to function as independent cancer researchers in an academic setting.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Iowa
Internal Medicine/Medicine
Schools of Medicine
Iowa City
United States
Zip Code
Geisler, J P; Buller, E; Manahan, K J (2008) Estrogen receptor alpha and beta expression in a case matched series of serous and endometrioid adenocarcinomas of the ovary. Eur J Gynaecol Oncol 29:126-8
Mente, Nolan R; Wiemer, Andrew J; Neighbors, Jeffrey D et al. (2007) Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric series. Bioorg Med Chem Lett 17:911-5
Geisler, John P; Manahan, Kelly J; Buller, Richard E (2006) Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol 100:53-7
Neighbors, Jeffrey D; Salnikova, Maya S; Beutler, John A et al. (2006) Synthesis and structure-activity studies of schweinfurthin B analogs: Evidence for the importance of a D-ring hydrogen bond donor in expression of differential cytotoxicity. Bioorg Med Chem 14:1771-84
Swenson, Wade T; Wooldridge, James E; Lynch, Charles F et al. (2005) Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 23:5019-26
Miller, Shannon L B; Jones, Laura E; Carney, Caroline P (2005) Psychiatric sequelae following breast cancer chemotherapy: a pilot study using claims data. Psychosomatics 46:517-22
Hendrix, Mary J C; Seftor, Elisabeth A; Hess, Angela R et al. (2003) Molecular plasticity of human melanoma cells. Oncogene 22:3070-5
Walker-Daniels, Jennifer; Hess, Angela R; Hendrix, Mary J C et al. (2003) Differential regulation of EphA2 in normal and malignant cells. Am J Pathol 162:1037-42
Hess, Angela R; Seftor, Elisabeth A; Seftor, Richard E B et al. (2003) Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res 63:4757-62
Geisler, John P; Goodheart, Michael J; Sood, Anil K et al. (2003) Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 98:2199-206

Showing the most recent 10 out of 14 publications